Mercaptopurine and Acute myeloid leukaemia - a phase IV clinical study of FDA data
Acute myeloid leukaemia is found among people who take Mercaptopurine, especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Mercaptopurine and have Acute myeloid leukaemia. It is created by eHealthMe based on reports of 19,865 people who have side effects when taking Mercaptopurine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
19,865 people reported to have side effects when taking Mercaptopurine.
Among them, 196 people (0.99%) have Acute myeloid leukaemia.
What is Mercaptopurine?
Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 17,983 Mercaptopurine users for its effectiveness, alternative drugs and more.
What is Acute myeloid leukaemia?
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 1,182 drugs and 919 conditions by eHealthMe.
Number of Mercaptopurine and Acute myeloid leukaemia reports submitted per year:
Time on Mercaptopurine when people have Acute myeloid leukaemia *:
Gender of people who have Acute myeloid leukaemia when taking Mercaptopurine*:
Age of people who have Acute myeloid leukaemia when taking Mercaptopurine *:
Common drugs people take besides Mercaptopurine *:
Common side effects people have besides Acute myeloid leukaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mercaptopurine and have Acute myeloid leukaemia?Check whether Acute myeloid leukaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Acute myeloid leukaemia and when was it recovered:
Expand to all the drugs that have ingredients of mercaptopurine:
Alternative drugs to, pros and cons of Mercaptopurine:
- Mercaptopurine (17,983 reports)
Common Mercaptopurine side effects:
Browse all side effects of Mercaptopurine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Acute myeloid leukaemia treatments and more:
- Acute myeloid leukaemia (46,541 reports)
COVID vaccines that are related to Acute myeloid leukaemia:
- Acute myeloid leukaemia in Moderna COVID Vaccine
- Acute myeloid leukaemia in Pfizer BioNTech Covid Vaccine
- Acute myeloid leukaemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Acute myeloid leukaemia:
All the drugs that are associated with Acute myeloid leukaemia:
- Acute myeloid leukaemia (1,182 drugs)
Common conditions associated with Acute myeloid leukaemia:
All the conditions that are associated with Acute myeloid leukaemia:
- Acute myeloid leukaemia (919 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mercaptopurine (the active ingredients of Mercaptopurine) and Mercaptopurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bidil and Weight Abnormal - 10 seconds ago
- Codeine and High Blood Cholesterol - 11 seconds ago
- Alprazolam and Otezla drug interaction - 12 seconds ago
- Augmentin Xr and Yaz drug interaction - 16 seconds ago
- Etoposide and Viral Infection - 19 seconds ago
- Axid Ar and Stroke - 19 seconds ago
- Xiidra and Eyelid Disorder - 22 seconds ago
- Hygroton and Rhabdomyolysis - 29 seconds ago
- Topicort and Nervousness - 30 seconds ago
- Quinapril and Renal Artery Stenosis - 31 seconds ago